Boyarko B, Podvin S, Greenberg B, Arnold S, Juanes A, van der Kant R
ACS Pharmacol Transl Sci. 2024; 7(10):2924-2935.
PMID: 39421657
PMC: 11480897.
DOI: 10.1021/acsptsci.4c00229.
Pai S
Aging Brain. 2024; 6:100121.
PMID: 39044776
PMC: 11263948.
DOI: 10.1016/j.nbas.2024.100121.
Guo J, Chen S, Zhang Y, Liu J, Jiang L, Hu L
MedComm (2020). 2024; 5(2):e476.
PMID: 38405060
PMC: 10893558.
DOI: 10.1002/mco2.476.
Latorre-Leal M, Rodriguez-Rodriguez P, Franchini L, Nikolidakis O, Daniilidou M, Delac L
Sci Adv. 2024; 10(4):eadj1354.
PMID: 38266095
PMC: 10807813.
DOI: 10.1126/sciadv.adj1354.
Kacher R, Mounier C, Caboche J, Betuing S
Front Aging Neurosci. 2022; 14:797220.
PMID: 35517051
PMC: 9063567.
DOI: 10.3389/fnagi.2022.797220.
Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
Dias I, Shokr H, Shephard F, Chakrabarti L
J Alzheimers Dis. 2022; 87(4):1527-1536.
PMID: 35491790
PMC: 9277668.
DOI: 10.3233/JAD-220083.
Gene losses in the common vampire bat illuminate molecular adaptations to blood feeding.
Blumer M, Brown T, Freitas M, Destro A, Oliveira J, Morales A
Sci Adv. 2022; 8(12):eabm6494.
PMID: 35333583
PMC: 8956264.
DOI: 10.1126/sciadv.abm6494.
Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases.
Pikuleva I
Explor Neuroprotective Ther. 2022; 1(3):159-172.
PMID: 35156102
PMC: 8835717.
DOI: 10.37349/ent.2021.00013.
Estrogen receptors and the aging brain.
Maioli S, Leander K, Nilsson P, Nalvarte I
Essays Biochem. 2021; 65(6):913-925.
PMID: 34623401
PMC: 8628183.
DOI: 10.1042/EBC20200162.
Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer's Disease.
Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S
Int J Mol Sci. 2021; 22(18).
PMID: 34576302
PMC: 8468637.
DOI: 10.3390/ijms221810139.
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications.
Pikuleva I, Cartier N
Front Aging Neurosci. 2021; 13:696778.
PMID: 34305573
PMC: 8297829.
DOI: 10.3389/fnagi.2021.696778.
Abnormal brain cholesterol homeostasis in Alzheimer's disease-a targeted metabolomic and transcriptomic study.
Varma V, Busra Luleci H, Oommen A, Varma S, Blackshear C, Griswold M
NPJ Aging Mech Dis. 2021; 7(1):11.
PMID: 34075056
PMC: 8169871.
DOI: 10.1038/s41514-021-00064-9.
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer's Disease.
Gamba P, Giannelli S, Staurenghi E, Testa G, Sottero B, Biasi F
Antioxidants (Basel). 2021; 10(5).
PMID: 34067119
PMC: 8151638.
DOI: 10.3390/antiox10050740.
Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.
Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z
Mol Neurobiol. 2021; 58(5):2183-2201.
PMID: 33411241
DOI: 10.1007/s12035-020-02232-6.
27-Hydroxycholesterol Promotes the Transfer of Astrocyte-Derived Cholesterol to Neurons in Co-cultured SH-SY5Y Cells and C6 Cells.
Wang Y, Zhang X, Wang T, Liu W, Wang L, Hao L
Front Cell Dev Biol. 2020; 8:580599.
PMID: 33330456
PMC: 7732486.
DOI: 10.3389/fcell.2020.580599.
Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes.
Petrov A, Mast N, Li Y, Denker J, Pikuleva I
Brain Commun. 2020; 2(1).
PMID: 32661514
PMC: 7357967.
DOI: 10.1093/braincomms/fcaa043.
In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.
Mast N, Verwilst P, Wilkey C, Guengerich F, Pikuleva I
J Med Chem. 2019; 63(12):6477-6488.
PMID: 31617715
PMC: 7226586.
DOI: 10.1021/acs.jmedchem.9b01383.
CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice.
Petrov A, Lam M, Mast N, Moon J, Li Y, Maxfield E
Neurotherapeutics. 2019; 16(3):710-724.
PMID: 31062296
PMC: 6694340.
DOI: 10.1007/s13311-019-00737-0.
Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
Petrov A, Pikuleva I
Neurotherapeutics. 2019; 16(3):635-648.
PMID: 31001737
PMC: 6694357.
DOI: 10.1007/s13311-019-00731-6.
24(),25-Epoxycholesterol and () overexpression promote midbrain dopaminergic neurogenesis .
Theofilopoulos S, Abreu de Oliveira W, Yang S, Yutuc E, Saeed A, Abdel-Khalik J
J Biol Chem. 2019; 294(11):4169-4176.
PMID: 30655290
PMC: 6422085.
DOI: 10.1074/jbc.RA118.005639.